FDA NDC Directory · JSON-LD · Markdown

Exemestane

NDC 68382-383 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202602
Dosage form / routeTABLET · ORAL
Active ingredientsEXEMESTANE (25 mg/1)
Marketing started20181008
Package count1

External sources

Source: openFDA. Public-domain (CC0).